{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:59:26Z","timestamp":1780639166805,"version":"3.54.1"},"reference-count":48,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Spinal muscular atrophy (SMA) is a severe neuromuscular disorder in which presymptomatic treatment substantially improves survival and motor outcomes, yet newborn screening for SMA remains unevenly implemented across Europe, and evidence from lower-resource health systems is needed to guide scale-up. In this study, we assessed the feasibility, diagnostic performance, and public health implications of implementing neonatal SMA screening in the Republic of Moldova within an established national newborn screening framework. A pilot genetic screening program was conducted using dried blood spot (DBS) samples collected through routine newborn screening workflows; SMN1 exon 7 deletion testing was performed by real-time polymerase chain reaction (qPCR), and positive findings were confirmed by multiplex ligation-dependent probe amplification (MLPA), alongside the evaluation of operational integration and system-level requirements. Screening was operationally feasible within existing DBS processes and demonstrated high analytical performance, consistent with published international experience, although performance results should be interpreted cautiously due to the limited sample size. Two SMA cases were confirmed in a small cohort, enabling early diagnosis and timely referral for disease-modifying therapy, and integration into the existing program was practical and resource-efficient. These findings support the incorporation of SMA into national newborn screening panels using DBS-based molecular methods, highlighting an implementable model for introducing advanced genetic testing within routine public health services.<\/jats:p>","DOI":"10.3390\/ijns12020038","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:36:18Z","timestamp":1780076178000},"page":"38","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Newborn Screening for Spinal Muscular Atrophy in the Republic of Moldova: A Feasibility Study and First Steps"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-397X","authenticated-orcid":false,"given":"Iulia","family":"Coliban","sequence":"first","affiliation":[{"name":"Human Molecular Genetics Laboratory, Institute of Mother and Child, MD-2062 Chisinau, Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-3933","authenticated-orcid":false,"given":"Natalia","family":"Usurelu","sequence":"additional","affiliation":[{"name":"Laboratory of Prevention of Hereditary Pathologies, Institute of Mother and Child, MD-2062 Chisinau, Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Opalco","sequence":"additional","affiliation":[{"name":"Center for Human Reproduction and Medical Genetics, Institute of Mother and Child, MD-2062 Chisinau, Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Gladun","sequence":"additional","affiliation":[{"name":"Institute of Mother and Child, MD-2062 Chisinau, Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sacara","sequence":"additional","affiliation":[{"name":"Human Molecular Genetics Laboratory, Institute of Mother and Child, MD-2062 Chisinau, Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Angilletta, I., Ferrante, R., Giansante, R., Lombardi, L., Babore, A., Dell\u2019elice, A., Alessandrelli, E., Notarangelo, S., Ranaudo, M., and Palmarini, C. (2023). Spinal muscular atrophy: An evolving scenario through new perspectives in diagnosis and advances in therapies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914873"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1017\/cjn.2020.229","article-title":"Newborn screening for spinal muscular atrophy: Ontario testing and follow-up recommendations","volume":"48","author":"McMillan","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7S18","DOI":"10.1016\/S0929-693X(20)30272-4","article-title":"Clinical features of spinal muscular atrophy (SMA) type 2","volume":"27","author":"Richelme","year":"2020","journal-title":"Arch. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clinimag.2018.09.017","article-title":"Lumbosacral ventral spinal nerve root atrophy identified on MRI in a case of spinal muscular atrophy type II","volume":"53","author":"Smith","year":"2019","journal-title":"Clin. Imaging"},{"key":"ref_5","first-page":"24","article-title":"Analysis of SMN1, NAIP and GTF2H2 gene status in correlation with spinal muscular atrophy","volume":"4","author":"Coliban","year":"2023","journal-title":"Mold. J. Heal. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chudakova, D., Kuzenkova, L., Fisenko, A., and Savostyanov, K. (2024). In search of spinal muscular atrophy disease modifiers. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252011210"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Larson, J.L., Silver, A.J., Chan, D., Borroto, C., Spurrier, B., and Silver, L.M. (2015). Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project. BMC Med. Genet., 16.","DOI":"10.1186\/s12881-015-0246-2"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/GIM.0b013e3181c5e713","article-title":"Perspectives and diagnostic considerations in spinal muscular atrophy","volume":"12","author":"Prior","year":"2010","journal-title":"Genet. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2147\/TCRM.S172291","article-title":"Clinical evidence supporting early treatment of patients with spinal muscular atrophy: Current perspectives","volume":"15","author":"Dangouloff","year":"2019","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy: A literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Costa-Roger, M., Blasco-P\u00e9rez, L., Cusc\u00f3, I., and Tizzano, E.F. (2021). The importance of digging into the genetics of SMN genes in the therapeutic scenario of spinal muscular atrophy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22169029"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-190424","article-title":"Advances in treatment of spinal muscular atrophy: New phenotypes, new challenges, new implications for care","volume":"7","author":"Schorling","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","article-title":"Spinal muscular atrophy: In the challenge lies a solution","volume":"44","author":"Wirth","year":"2021","journal-title":"Trends Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.spen.2021.100878","article-title":"Spinal muscular atrophy","volume":"37","author":"Nicolau","year":"2021","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/acn3.689","article-title":"Novel challenges in spinal muscular atrophy: How to screen and whom to treat?","volume":"6","author":"Saffari","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Po\u017eun, N., Perko, D., Anastasovska, V., Bari\u0107, I., Ba\u0161a, M., Battelino, T., Biland\u017eija, I., Brincat, I., Brku\u0161anin, M., and Djordevi\u0107, M. (2026). Current status of newborn screening in Southeastern and Central Europe. Int. J. Neonatal Screen., 1.","DOI":"10.3390\/ijns12010014"},{"key":"ref_17","unstructured":"Sacar\u0103, V. (2019). The Molecular-Genetic Features of the Neuromuscular Pathologies Frequently Encountered in the Republic of Moldova. [Ph.D. Thesis, Academy of Science of Moldova]. Available online: http:\/\/www.cnaa.md\/files\/theses\/2019\/55307\/victoria_sacara_thesis.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1134\/S1022795408100128","article-title":"Molecular genetic characteristics of Duchenne-Becker muscular dystrophy in the Republic of Moldova","volume":"44","author":"Sacare","year":"2008","journal-title":"Russ. J. Genet."},{"key":"ref_19","first-page":"166","article-title":"Perspective of neonatal screening of spinal muscular atrophy","volume":"1","author":"Coliban","year":"2022","journal-title":"Bul. Perinatol."},{"key":"ref_20","first-page":"38","article-title":"Spinal muscular atrophy: News and perspectives","volume":"86","author":"Coliban","year":"2020","journal-title":"Bul. Perinatol."},{"key":"ref_21","unstructured":"Bureau of Statistics of R. of Moldova (2026, March 06). Statistica.gov.md, Available online: https:\/\/statistica.gov.md\/ro\/statistic_domains."},{"key":"ref_22","first-page":"35","article-title":"Physical therapy services received by individuals with spinal muscular atrophy (SMA)","volume":"9","author":"Dunaway","year":"2016","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JND-180304","article-title":"Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_24","unstructured":"Ministry of Health of Moldova (2026, March 09). Clinical National Protocol for SMA, No. 402, ed. 1, 2022, Available online: https:\/\/ms.gov.md\/wp-content\/uploads\/2022\/06\/PCN-402-Atrofia-musculara-spinala.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"(2013). World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_28","unstructured":"Thermo Fisher Scientific (2025, November 14). GeneJET Genomic DNA Purification Kit, Catalog Numbers K0721, K0722. Available online: https:\/\/www.thermofisher.com\/order\/catalog\/product\/K0721."},{"key":"ref_29","unstructured":"Holland, M.R.C. (2025, November 14). SALSA MLPA Probemix P021-B1 SMA. Available online: https:\/\/www.mrcholland.com\/product\/P021."},{"key":"ref_30","first-page":"39","article-title":"Neonatal genetic screening as a tool in the early diagnosis of spinal muscular atrophy","volume":"29","author":"Coliban","year":"2023","journal-title":"Rom. J. Child. Adolesc. Neurol. Psychiatry"},{"key":"ref_31","first-page":"68","article-title":"Clinical and molecular-genetic features of the neuromuscular pathologies in Republic of Moldova","volume":"23","year":"2017","journal-title":"Rom. J. Child. Adolesc. Neurol. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening","volume":"190","author":"Chien","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Aragon-Gawinska, K., Mouraux, C., Dangouloff, T., and Servais, L. (2023). Spinal muscular atrophy treatment in patients identified by newborn screening-A systematic review. Genes, 14.","DOI":"10.3390\/genes14071377"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cooper, K., Nalbant, G., Sutton, A., Harnan, S., Thokala, P., Chilcott, J., McNeill, A., and Bessey, A. (2024). Systematic review of newborn screening programmes for spinal muscular atrophy. Int. J. Neonatal Screen., 10.","DOI":"10.3390\/ijns10030049"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gailite, L., Sterna, O., Konika, M., Isakovs, A., Isakova, J., Micule, I., Setlere, S., Diriks, M., and Auzenbaha, M. (2022). New-born screening for spinal muscular atrophy: Results of a Latvian pilot study. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8010015"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Leanca, M.C., Onose, G., Nicolae, G., Neagu, E., Vasile, D., Bercu, E., Balanescu, O.M., Capitanescu, A., Munteanu, C., and Popescu, C. (2026). Neonatal genetic screening results for spinal muscular atrophy in Romania: Insights from a 3-years pilot program. Int. J. Neonatal Screen., 12.","DOI":"10.3390\/ijns12010006"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lin, Y., Lin, C.-H., Yin, X., Zhu, L., Yang, J., Shen, Y., Yang, C., Chen, X., Hu, H., and Ma, Q. (2019). Newborn screening for spinal muscular atrophy in China using DNA mass spectrometry. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.01255"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Romanelli Tavares, V.L., Monfardini, F., Louren\u00e7o, N.C.V., da Rocha, K.M., Weinmann, K., Pavanello, R., and Zatz, M. (2021). Newborn screening for 5q spinal muscular atrophy: Comparisons between real-time PCR methodologies and cost estimations for future implementation programs. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7030053"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nmd.2019.02.003","article-title":"Newborn screening for SMA in Southern Belgium","volume":"29","author":"Boemer","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-021-01783-8","article-title":"Newborn screening for spinal muscular atrophy in Germany: Clinical results after 2 years","volume":"16","author":"Vill","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Shinohara, M., Niba, E.T.E., Wijaya, Y.O.S., Takayama, I., Mitsuishi, C., Kumasaka, S., Kondo, Y., Takatera, A., Hokuto, I., and Morioka, I. (2019). A novel system for spinal muscular atrophy screening in newborns: Japanese pilot study. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5040041"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41436-019-0673-0","article-title":"The implementation of newborn screening for spinal muscular atrophy: The Australian experience","volume":"22","author":"Kariyawasam","year":"2020","journal-title":"Genet. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jval.2022.06.010","article-title":"Cost-effectiveness of newborn screening for spinal muscular atrophy in the Netherlands","volume":"25","author":"Velikanova","year":"2022","journal-title":"Value Health"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40120-023-00489-2","article-title":"Cost-effectiveness of newborn screening for spinal muscular atrophy in England","volume":"12","author":"Weidlich","year":"2023","journal-title":"Neurol. Ther."},{"key":"ref_45","unstructured":"Coliban, I., Sacar\u0103, V., U\u0219urelu, N., Opalco, I., Palii, I., and Gladun, S. (2025). Protocol of \u201cNeonatal Genetic Screening for Spinal Muscular Atrophy\u201d, State Agency for Intellectual Property of Moldova. Available online: https:\/\/www.db.agepi.md\/opere\/Details.aspx?RealID=7737&lang=ro."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: A review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000272898","article-title":"Guiding policy decisions for genetic screening: Developing a systematic and transparent approach","volume":"14","author":"Andermann","year":"2011","journal-title":"Public Health Genom."},{"key":"ref_48","unstructured":"Agency for Medicine and Medical Devices of R. of Moldova (2026, February 06). Registration Certificate nr. 27524 for Evrysdi 0.75 mg\/mL in Republic of Moldova, Available online: https:\/\/nomenclator.amdm.gov.md\/."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/2\/38\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:59:33Z","timestamp":1780635573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/12\/2\/38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijns12020038"],"URL":"https:\/\/doi.org\/10.3390\/ijns12020038","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}